Pila Pharma: €50k

Case

Pila Pharma has identified key missing components in the treatment of Type 2 Diabetes. Pila Pharma was granted € 50k from the SME Instrument HORIZON 2020, phase 1. GAEU’s team at Horizon 2020 Centre of Excellence wrote the proposal.